Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000289576 | SCV000343010 | uncertain significance | not provided | 2016-07-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001088292 | SCV001003776 | likely benign | Duchenne muscular dystrophy | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002374480 | SCV002684454 | uncertain significance | Cardiovascular phenotype | 2023-02-14 | criteria provided, single submitter | clinical testing | The p.P2893S variant (also known as c.8677C>T), located in coding exon 59 of the DMD gene, results from a C to T substitution at nucleotide position 8677. The proline at codon 2893 is replaced by serine, an amino acid with similar properties. Based on data from gnomAD, the T allele has an overall frequency of 0.0033% (6/182473) total alleles studied, with 3 hemizygote(s) observed. The highest observed frequency was 0.0074% (6/81076) of European (non-Finnish) alleles. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV000289576 | SCV003829483 | uncertain significance | not provided | 2020-09-24 | criteria provided, single submitter | clinical testing |